I think the answer is staring us in the face. Currently USD wise we are worth almost the same price as the Livent spin off as a 100% Responsible Trading Ofcourse.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%